Home > News > Top Researchers, Drugmakers, and Regulators Convene at CancerNano 2007
January 30th, 2007
Top Researchers, Drugmakers, and Regulators Convene at CancerNano 2007
Abstract:
The world's top cancer researchers, clinicians, drugmakers and regulators will gather at a special symposium during Nanotech 2007 to explore how to speed up ways to move the most promising cancer-fighting nanotechnology research into clinical trials.
The CancerNano 2007 symposium will be held during Nanotech 2007 (May 20-24, 2007 in Santa Clara, California). Attending the event will be experts from the National Cancer Institute, the National Institutes of Health, the U.S. Food and Drug Administration and leading researchers from Genentech, Pfizer, Stanford University, UCLA, and the California Institute of Technology.
Source:
nsti.org
Related News Press |
Nanomedicine
Exosomes: A potential biomarker and therapeutic target in diabetic cardiomyopathy November 8th, 2024
Unveiling the power of hot carriers in plasmonic nanostructures August 16th, 2024
Announcements
Nanotechnology: Flexible biosensors with modular design November 8th, 2024
Exosomes: A potential biomarker and therapeutic target in diabetic cardiomyopathy November 8th, 2024
Turning up the signal November 8th, 2024
Nanofibrous metal oxide semiconductor for sensory face November 8th, 2024
Human Interest/Art
Drawing data in nanometer scale September 30th, 2022
Scientists prepare for the world’s smallest race: Nanocar Race II March 18th, 2022
Graphene nanotubes revolutionize touch screen use for prosthetic hands August 3rd, 2021
JEOL Announces 2020 Microscopy Image Grand Prize Winners January 7th, 2021
Events/Classes
A New Blue: Mysterious origin of the ribbontail ray’s electric blue spots revealed July 5th, 2024
Researchers demonstrate co-propagation of quantum and classical signals: Study shows that quantum encryption can be implemented in existing fiber networks January 20th, 2023
The latest news from around the world, FREE | ||
Premium Products | ||
Only the news you want to read!
Learn More |
||
Full-service, expert consulting
Learn More |
||